Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Cboe UK GBp

Dr. Martens plc (DOCSL.XC)

Compare
49.44
+0.36
+(0.73%)
At close: April 4 at 4:29:39 PM GMT+1
Loading Chart for DOCSL.XC
  • Previous Close 49.08
  • Open 48.98
  • Bid 47.48 x --
  • Ask 50.50 x --
  • Day's Range 47.09 - 49.70
  • 52 Week Range 47.09 - 99.05
  • Volume 1,278,420
  • Avg. Volume 142,986
  • Market Cap (intraday) 477.757M
  • Beta (5Y Monthly) 0.07
  • PE Ratio (TTM) 1,648.00
  • EPS (TTM) 0.03
  • Earnings Date --
  • Forward Dividend & Yield 0.02 (3.72%)
  • Ex-Dividend Date Mar 6, 2025
  • 1y Target Est --

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company was founded in 1945 and is based in London, the United Kingdom.

www.drmartensplc.com

2,630

Full Time Employees

March 31

Fiscal Year Ends

Recent News: DOCSL.XC

View More

Performance Overview: DOCSL.XC

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

DOCSL.XC
31.92%
FTSE 100 (^FTSE)
1.44%

1-Year Return

DOCSL.XC
48.43%
FTSE 100 (^FTSE)
0.99%

3-Year Return

DOCSL.XC
81.77%
FTSE 100 (^FTSE)
6.56%

5-Year Return

DOCSL.XC
81.77%
FTSE 100 (^FTSE)
48.74%

Compare To: DOCSL.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DOCSL.XC

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    473.52M

  • Enterprise Value

    828.32M

  • Trailing P/E

    17.05

  • Forward P/E

    10.18

  • PEG Ratio (5yr expected)

    5.09

  • Price/Sales (ttm)

    0.59

  • Price/Book (mrq)

    1.42

  • Enterprise Value/Revenue

    1.03

  • Enterprise Value/EBITDA

    5.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.65%

  • Return on Assets (ttm)

    4.53%

  • Return on Equity (ttm)

    8.42%

  • Revenue (ttm)

    805.9M

  • Net Income Avi to Common (ttm)

    29.4M

  • Diluted EPS (ttm)

    0.03

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    94.9M

  • Total Debt/Equity (mrq)

    134.44%

  • Levered Free Cash Flow (ttm)

    189.08M

Research Analysis: DOCSL.XC

View More

Company Insights: DOCSL.XC

Research Reports: DOCSL.XC

View More

People Also Watch